Diagnostics for the Real World

Product Enquiry Careers Location
  • About us
  • Solution
    • Products
    • Product Evaluations
    • Products coming soon
    • Products Pipeline
  • News & Events
    • News
    • Press Release
    • Events
    • Gallery
  • Distribution
  • Certificates & Publications
    • Certificates
    • Publications
  • Support
    • Technical FAQs
    • Certificate of Analysis
  • Careers
  • Location
  • Contact Us
  • Home
  • Certificate & Publications
  • Publications

Publications

  • WHO consolidated guidelines on tuberculosis: module 3: diagnosis - rapid diagnostics for tuberculosis detection: 2021 update Download

    Module 3: diagnosis – rapid diagnostics for tuberculosis detection

  • WHO consolidated guidelines on tuberculosis: module 3: diagnosis - rapid diagnostics for tuberculosis detection: web annex 4: evidence synthesis and analysis, 2021 update Download

    Module 3: diagnosis – rapid diagnostics for tuberculosis detection 

  • WHO operational handbook on tuberculosis Download

    Module 3 : Diagnosis -Rapid Diagnostics for tuberculosis detection, World Health Organization (WHO) 

  • Development of ‘TrueNat’ Innovation System in India for Detection of Tuberculosis and COVID-19: A System Based Perspective Download

    Nidhi Singh and Kirti Tyagi, RIS Discussion Paper Series, Discussion Paper # 257, October 2020

     In this study, an attempt is made to present the characteristics of an ecosystem for the successful development of indigenous diagnostic technology, called ‘TrueNat’, which have dealt the context-specific challenges associated with Tuberculosis (TB) diagnostics and has been validated by the Indian Council of Medical Research for addressing the specific challenges related to COVID-19 testing.

  • India Banks on Decentralized Molecular COVID-19Testing Download

    Madeleine Johnson, Genome Web, Oct 09,2020

    Decentralized molecular testing is gaining ground for SARS-CoV-2 diagnosis in India. Due inpart to a robust anti-tuberculosis campaign, the testing modality has made inroads into the country'scomplex and tiered healthcare system during the past decade. Now, decentralized platforms from firms likeMolBio Diagnostics and Cepheid, as well as newcomer Tata Group, are starting to play a significant role inCOVID-19 diagnostic testing in India as well.

  • India's MolBio Brings Tuberculosis MDx to Point of Care With Help From FIND Download

    Madeleine Johnson, Genome Web, Sept 19,2018

    NEW YORK (GenomeWeb) – MolBio, a Goa, India-based molecular diagnostics manufacturer, is bringing tuberculosis testing closer to patients in its home country, potentially competing with imported testing. MolBio's point-of-care real-time PCR system and infectious disease assays are currently commercially available in India, and the Foundation for Innovation of New Diagnostics (FIND) is now assisting the firm with clinical trials of its TB test system prior to review by the World Health Organization for potential prequalification.

Plot No. L-46, Phase II D,
Verna Industrial Estate, Verna,
Goa - 403 722, India

+91-832-6724888

[email protected]

[email protected]

Join us

Molbio Diagnostics Pvt. Ltd. © 2023 All Rights Reserved

Designed by Team Inertia Technologies